These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8292065)

  • 1. Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
    Caraco Y; Zylber-Katz E; Granit L; Levy M
    Arzneimittelforschung; 1993 Nov; 43(11):1204-8. PubMed ID: 8292065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma kinetics of dipyrone metabolites in rapid and slow acetylators.
    Levy M; Flusser D; Zylber-Katz E; Granit L
    Eur J Clin Pharmacol; 1984; 27(4):453-8. PubMed ID: 6519153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation and excretion of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1992; 42(2):187-91. PubMed ID: 1618251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators.
    Levy M; Safadi R; Zylber-Katz E; Granit L; Caraco Y
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):461-5. PubMed ID: 11699610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1985; 29(1):67-71. PubMed ID: 4054207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyrone metabolism in liver disease.
    Zylber-Katz E; Caraco Y; Granit L; Levy M
    Clin Pharmacol Ther; 1995 Aug; 58(2):198-209. PubMed ID: 7648770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone.
    Cohen O; Zylber-Katz E; Caraco Y; Granit L; Levy M
    Eur J Clin Pharmacol; 1998 Sep; 54(7):549-53. PubMed ID: 9832297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent pharmacokinetics of metabolites of dipyrone in saliva.
    Neddermann E; Rohdewald P
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):105-11. PubMed ID: 3208789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dipyrone, acetylsalicylic acid and acetaminophen on human neutrophil chemotaxis.
    Matzner Y; Drexler R; Levy M
    Eur J Clin Invest; 1984 Dec; 14(6):440-3. PubMed ID: 6441720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeine.
    Agúndez JA; Carrillo JA; Martínez C; Benítez J
    Ther Drug Monit; 1995 Feb; 17(1):1-5. PubMed ID: 7725368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of dipyrone metabolites in human breast milk.
    Zylber-Katz E; Linder N; Granit L; Levy M
    Eur J Clin Pharmacol; 1986; 30(3):359-61. PubMed ID: 3732376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium.
    Vlahov V; Badian M; Verho M; Bacracheva N
    Eur J Clin Pharmacol; 1990; 38(1):61-5. PubMed ID: 2328750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age on the pharmacokinetics of dipyrone.
    Zylber-Katz E; Granit L; Stessman J; Levy M
    Eur J Clin Pharmacol; 1989; 36(5):513-6. PubMed ID: 2753071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of antipyrine metabolites in human plasma by solid-phase extraction and micellar liquid chromatography.
    Carretero I; Vadillo JM; Laserna JJ
    Analyst; 1995 Jun; 120(6):1729-32. PubMed ID: 7604956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cimetidine on the pharmacokinetics of the metabolites of metamizol.
    Bacracheva N; Tyutyulkova N; Drenska A; Gorantcheva J; Schinzel S; Scholl T; Stoinov A; Tchakarski I; Tentcheva J; Vlahov V
    Int J Clin Pharmacol Ther; 1997 Jul; 35(7):275-81. PubMed ID: 9247840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis B virus.
    Levy M; Leibowich I; Zylber-Katz E; Ilan Y; Granit L; Sviri S; Caraco Y
    Clin Pharmacol Ther; 1997 Jul; 62(1):6-14. PubMed ID: 9246014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of dipyrone and its metabolites.
    Levy M; Zylber-Katz E; Rosenkranz B
    Clin Pharmacokinet; 1995 Mar; 28(3):216-34. PubMed ID: 7758252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability of two oral metamizole formulations. Influence of the acetylation phenotype.
    Bacracheva N; Drenska A; Gorantcheva J; Tyutyulkova N; Vlahov V
    Arzneimittelforschung; 1995 Mar; 45(3):282-5. PubMed ID: 7741785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodegradation study of three dipyrone metabolites in various water systems: identification and toxicity of their photodegradation products.
    Gómez MJ; Sirtori C; Mezcua M; Fernández-Alba AR; Agüera A
    Water Res; 2008 May; 42(10-11):2698-706. PubMed ID: 18294672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thin-layer chromatographic determination of major metamizole metabolites in serum and urine.
    Sistovaris N; Pola W; Wolhoff H
    J Chromatogr; 1983 May; 274():289-98. PubMed ID: 6874829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.